Prostate cancer trends in the era of prostate-specific antigen: An update of incidence, mortality, and clinical factors from the SEER database
- 28 February 2002
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 29 (1), 173-181
- https://doi.org/10.1016/s0094-0143(02)00002-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Gleason Score 2–4 Adenocarcinoma of the Prostate on Needle BiopsyThe American Journal of Surgical Pathology, 2000
- Implications of Stage-Specific Survival Rates in Assessing Recent Declines in Prostate Cancer Mortality RatesEpidemiology, 2000
- TRENDS IN MORTALITY RATES IN PATIENTS WITH PROSTATE CANCER DURING THE ERA OF PROSTATE SPECIFIC ANTIGEN SCREENINGJournal of Urology, 2000
- Role of Transurethral Resection of the Prostate in Population-based Prostate Cancer Incidence RatesAmerican Journal of Epidemiology, 1999
- Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate CancerJAMA, 1998
- Correlation of Prostate Needle Biopsy and Radical Prostatectomy Gleason Grade in Academic and Community SettingsThe American Journal of Surgical Pathology, 1997
- The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence--Data from the Utah Cancer RegistryCancer, 1996
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerPublished by American Medical Association (AMA) ,1995